Temozolamide

Red

Brand Name(s):Temodal

Indication:Malignant gliomas

Rationale:4,8

Considered:Jul-07

Review Date:Mar-21

Comments:
Updated NICE TA23
Mar-16

MHRA Drug Safety Update
http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON364167
January 2014

NICE TA121